Ulf Kahlert is a member of Work group 3 – Preclinical Models – in the European Cost Action Nano2Clinic CA17140 Cancer Nanomedicine – from the bench to the bedside.

A cooperation project on therapy resistance with Capital Medical University Beijing, China and the Chinese Glioma Genome Atlas (GGGA) was funded through the Sino-German Science Center.

In cooperation with the Department of Inorganic Chemistry of HHU we developed a synthesis method for rapid and reproducible generation of gold nanoparticles to function as carriers to transfect brain cancer cells.